Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms

Platelets

Volumn 20, Issue 1, 2009, Pages 50-57

  Winning, Johannes ^a   Reichel, Julia ^a   Eisenhut, Yvonne ^b   Hamacher, Jürg ^b   Kohl, Matthias ^c   Deigner, Hans Peter ^c   Claus, Ralf A ^a   Bauer, Michael ^a   Lösche, Wolfgang ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c SIRS Lab GmbH   (Germany)

Author keywords

Anti platelet drugs; Organ failure; Pneumonia; Systemic inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CLOPIDOGREL; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR 1; LIPOPOLYSACCHARIDE; TICLOPIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA MICROARRAY; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; FIBRIN DEPOSITION; GENETIC REGULATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LOW DRUG DOSE; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SEPTIC SHOCK; THROMBOCYTE COUNT; TREATMENT OUTCOME; UPREGULATION;

ADULT; AGED; ANIMALS; CELL LINE; FEMALE; FIBRIN; GENE EXPRESSION PROFILING; HEMODYNAMICS; HUMANS; INFECTION; INTENSIVE CARE UNITS; LENGTH OF STAY; LEUKOCYTES; LUNG; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PNEUMONIA; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TICLOPIDINE;

ANIMALIA; ESCHERICHIA COLI; MUS;

EID: 61649127576     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100802503368     Document Type: Article

References (48)

1. Russwurm S, Vickers J, Meier-Hellmann A, Bredl D, Spangenberg P, Reinhart K, Lösche W. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock 2002;17:263-268.
2. Levi M. Platelets in sepsis. Hematology 2005;10(Suppl 1):129-131.
3. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med 2002;30(5 Suppl):S313-S317.
4. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med 2002;30:753-756.
5. Sharma B, Sharma M, Majumder M, Steier W, Sangal A, Kalawar M. Thrombocytopenia in septic shock patients - A prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care 2007;35:874-880.
6. Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar JR, Adrie C, Vincent F, Cohen Y, Schlemmer B, et al. Platelet count decline: An early prognostic marker in critically ill patients with prolonged ICU stays. Chest 2007;131:1735-1741.
7. Weyrich AS, Zimmerman GA. Platelets: Signaling cells in the immune continuum. Trends Immunol 2004;25:489-495.
8. Sprague DL, Sowa JM, Elzey BD, Ratliff TL. The role of platelet CD154 in the modulation in adaptive immunity. Immunol Res 2007;39(1-3):185-193.
9. Steinhubl SR. Platelets as mediators of inflammation. Hematol/oncol clin North Am 2007 Feb;21(1):115-121.
10. Kuckleburg CJ, Tiwari R, Czuprynski CJ. Endothelial cell apoptosis induced by bacteria-activated platelets requires caspase-8 and -9 and generation of reactive oxygen species. Thromb Haemost 2008;99:363-372.
11. Ma AC, Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost 2008;6:415-420.
12. Chaer RA, Graham JA, Mureebe L. Platelet function and pharmacologic inhibition. Vasc Endovascular Surg 2006;40:261-267.
13. Pu Q, Wiel E, Corseaux D, Bordet R, Azrin MA, Ezekowitz MD, Lund N, Jude B, Vallet B. Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock. Crit Care Med 2001;29:1181-1188.
14. Taylor FB, Coller BS, Chang AC, Peer G, Jordan R, Engellener W, Esmon CT. 7E3 F(ab′)2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli. Blood 1997;89:4078-4084.
15. Storey RF. Biology and pharmacology of the platelet P2Y12 receptor. Curr Pharm Des 2006;12:1255-1259.
16. Evangelista V, Manarini S, Dell'Elba G, Martelli N, Napoleone E, Di Santo A, Lorenzet PS. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation. Thromb Haemost 2005;94:568-577.
17. Evangelista V, dell'Elba G, Martelli N, Amore C, Pecce R, Piccoli A, Manarini S, Totani L. Anti-inflammatory effects of clopidogrel in the mouse. J Thromb Haemost 2007;5 (Suppl 2):P-M-283.
18. Lipcsey M, Larsson A, Olovsson M, Sjolin J, Eriksson MB. Early endotoxin-mediated haemostatic and inflammatory responses in the clopidogrel-treated pig. Platelets 2005;16:408-414.
19. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Eng J Med 1997;336:973-979.
20. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999;100:793-798.
21. Cyrus T, Sung S, Zhao L, Funk CD, Tang S, Pratico D. Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 2002;106:1282-1287.
22. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754-1758.
23. Plehm R, Barbosa ME, Bader M. Animal models for hypertension/blood pressure recording. Methods Mol Med 2006;129:115-126.
24. Setzer F, Oberle V, Blaess M, Mö ller E, Russwurm S, Deigner HP, Claus RA, Bauer M, Reinhart K, Lösche W. Platelet-derived microvesicles induce differential gene expression in monocytic cells: A DNA microarray study. Platelets 2006;17:571-576.
25. Sedlacek M, Gemery JM, Cheung AL, Bayer AS, Remillard BD. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis 2007;49:401-408.
26. Kupferwasser LI, Yeaman MR, Nast CC, Kupferwasser D, Xiong YQ, Palma M, Cheung AL, Bayer AS. Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003;112:222-233.
27. Czabanka M, Peter C, Martin E, Walther A. Microcirculatory endothelial dysfunction during endotoxemia - Insights into pathophysiology, pathologic mechanisms and clinical relevance. Curr Vasc Pharmacol 2007;5:266-275.
28. Vaudo G, Marchesi S, Siepi D, Brozzetti M, Lombardini R, Pirro M, Alaeddin A, Roscini AR, Lupattelli G, Mannarino E. Human endothelial impairment in sepsis. Atherosclerosis 2008;197:747-752.
29. Husain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 1998;97:716-720.
30. Noon JP, Walker BR, Hand MF, Webb DJ. Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. Cardiovasc Res 1998;38:480-484.
31. Kharbanda RK, Walton B, Allen M, Klein N, Hingorani AD, MacAllister RJ, Vallance P. Prevention of inflammation-induced endothelial dysfunction: A novel vasculo-protective action of aspirin. Circulation 2002;105:2600-2604.
32. Gambim MH, do Carmo Ade O, Marti L, Verissimo-Filho S, Lopes LR, Janiszewski M. Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: Experimental evidence for a novel mechanism of septic vascular dysfunction. Crit Care 2007;11:R107.
33. Walther A, Czabanka M, Gebhard MM, Martin E. Glycoprotein IIB/IIIA-inhibition and microcirculatory alterations during experimental endotoxemia - An intravital microscopic study in the rat. Microcirculation 2004;11:79-88.
34. Kobayashi K, Yamanaka H, Fukuoka T, Dai Y, Obata K, Noguchi K. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci 2008;28:2892-2902.
35. Tu X, Chen X, Xie Y, Shi S, Wang J, Chen Y, Li J. Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury. J Am Soc Nephrol 2008;19:77-83.
36. Ohtaki Y, Shimauchi H, Yokochi T, Takada H, Endo Y. In vivo platelet response to lipopolysaccharide in mice: Proposed method for evaluating new antiplatelet drugs. Thromb Res 2002;108:303-309.
37. Zhao L, Ohtaki Y, Yamaguchi K, Matsushita M, Fujita T, Yokochi T, Takada H, Endo Y. LPS-induced platelet response and rapid shock in mice: Contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system. Blood 2002;100:3233-3239.
38. Solheim S, Pettersen AA, Arnesen H, Seljeflot I. No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease. Thromb Haemost 2006;96:660-664.
39. Steinhubl SR, Badimon JJ, Bhatt DL, Herbert JM, Luscher TF. Clinical evidence for anti-inflammatory effects of anti-platelet therapy in patients with atherothrombotic disease. Vasc Med 2007;12:113-122.
40. Li M, Zhang Y, Ren H, Zhang Y, Zhu X. Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis 2007;194:348-356.
41. Tomic V, Russwurm S, Mö ller E, Claus RA, Blaess M, Brunkhorst F, Bruegel M, Bode K, Bloos F, Wippermann J, et al. Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation 2005;112:2912-2920.
42. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995;25:843-851.
43. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-1905.
44. Weyrich AS, Kraiss LW, Prescott SM, Zimmerman GA. New roles for an old drug: Inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates. Trends Cardiovasc Med 2006;16:75-80.
45. Graff J, Harder S, Wahl O, Scheuermann EH, Gossmann J. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: Effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers. Clin Pharmacol Ther 2005;78:468-476.
46. Mykietiuk A, Carratalà J, Domínguez A, Manzur A, Fernández-Sabé N, Dorca J, Tubau F, Manresa F, Gudiol F. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with communityacquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2006;25:457-462.
47. Laterre PF. Clinical trials in severe sepsis with drotrecogin alfa (activated). Crit Care 2007;11(Suppl 5):S5.
48. Feistritzer C, Wiedermann CJ. Effects of anticoagulant strategies on activation of inflammation and coagulation. Expert Opin Biol Th 2007;7:855-870.